There were 647 press releases posted in the last 24 hours and 149,774 in the last 365 days.

Cellceutix: Consumption, Demand, Sales, Competitor and Forecast 2016 – 2021

Cellceutix Global Market 2016 Analysis and Forecast to 2021

PUNE, INDIA, September 23, 2016 / -- The report provides comprehensive information on the therapeutics under development by Cellceutix Corporation, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects.

Complete Report @

Report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

- The report provides a snapshot of the pipeline therapeutic landscape of Cellceutix Corporation
- The report provides overview of Cellceutix Corporation including its business description, key facts, and locations and subsidiaries
- The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
- The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
- The report assesses Cellceutix Corporation’s pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type
- The report features Cellceutix Corporation’s out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects

Get Sample Report @

Reasons to buy
- Evaluate Cellceutix Corporation’s strategic position with total access to detailed information on its product pipeline
- Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of therapeutics under development for Cellceutix Corporation
- Identify potential new clients or partners in the target demographic
- Plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics
- Devise corrective measures for pipeline projects by understanding Cellceutix Corporation’s pipeline depth and focus of pipeline therapeutics
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope

Have any query @

Key Points from Table of Content
Cellceutix Corporation - Research and Development Overview 7
Key Therapeutic Areas 7
Cellceutix Corporation - Pipeline Review 14
Pipeline Products by Stage of Development 14
Pipeline Products - Monotherapy 15
Cellceutix Corporation - Pipeline Products Glance 16
Cellceutix Corporation - Clinical Stage Pipeline Products 16
Cellceutix Corporation - Early Stage Pipeline Products 18
Cellceutix Corporation - Drug Profiles 22
brilacidin tetrahydrochloride 22
KM-133 25
KM-3174 27
CC-1807 31
CTIX-1278 32
CTIX-1502 33
KM-277 34
KM-278 35
KM-362 36
KM-391 37
KM-732 39
PMX-0196 40
PMX-0243 41
PMX-10072 43
PMX-10098 44
PMX-1207 45

Buy now @

Norah Trent
+1 646 845 9349 / +44 208 133 9349
email us here